{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T07:53:47Z","timestamp":1790409227835,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003091","name":"Shandong Province Natural Science Fund Project","doi-asserted-by":"publisher","award":["ZR2017LH034"],"award-info":[{"award-number":["ZR2017LH034"]}],"id":[{"id":"10.13039\/501100003091","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shandong Medical and Healthy Science Technology Development Plan","award":["2016WS0183"],"award-info":[{"award-number":["2016WS0183"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jneuroim.2019.577042","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T11:20:21Z","timestamp":1566818421000},"page":"577042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Intravenous immunoglobulin promotes the proliferation of CD4+CD25+ Foxp3+ regulatory T cells and the cytokines secretion in patients with Guillain-Barr\u00e9 syndrome in vitro"],"prefix":"10.1016","volume":"336","author":[{"given":"Guorong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xungang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2019.577042_bb0005","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2019.577042_bb0010","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jneuroim.2007.09.034","article-title":"Abnormality of circulating CD4+CD25+ regulatory T cell in patients with Guillain-Barr\u00e9 syndrome","volume":"192","author":"Chi","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2019.577042_bb0015","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1182\/blood-2008-02-138073","article-title":"Activation of natural regulatory T cells by IgG fc-derived peptide \"Tregitopes\"","volume":"112","author":"De Groot","year":"2008","journal-title":"Blood."},{"key":"10.1016\/j.jneuroim.2019.577042_bb0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria","volume":"137","author":"Fokke","year":"2014","journal-title":"Brain."},{"key":"10.1016\/j.jneuroim.2019.577042_bb0025","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"Plasma exchange\/Sandoglobulin Guillain-Barr\u00e9 syndrome trial group. Electrophysiological classification of Guillain-Barr\u00e9 syndrome: clinical associations and outcome","volume":"44","author":"Hadden","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2019.577042_bb0030","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1212\/01.WNL.0000061615.77865.83","article-title":"Anti-GM1 antibody IgG subclass: a clinical recovery predictor in Guillain-Barr\u00e9 syndrome","volume":"60","author":"Koga","year":"2003","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2019.577042_bb0035","doi-asserted-by":"crossref","DOI":"10.1111\/xen.12355","article-title":"Induction of porcine-specific regulatory T cells with high specificity and expression of IL-10 and TGF-beta1 using baboon-derived tolerogenic dendritic cells","volume":"25","author":"Li","year":"2018","journal-title":"Xenotransplantation."},{"key":"10.1016\/j.jneuroim.2019.577042_bb0040","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12026-014-8580-6","article-title":"Intravenous immunoglobulin exerts reciprocal regulation of Th1\/Th17 cells and regulatory T cells in Guillain-Barr\u00e9 syndrome patients","volume":"60","author":"Maddur","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jneuroim.2019.577042_bb0045","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell."},{"key":"10.1016\/j.jneuroim.2019.577042_bb0050","article-title":"Guillain-barr\u00e9 syndrome animal model: the first proof of molecular mimicry in human autoimmune disorder","volume":"2011","author":"Shahrizaila","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.jneuroim.2019.577042_bb0055","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1189\/jlb.0912441","article-title":"Regulatory T cell epitopes (Tregitopes) in IgG induce tolerance in vivo and lack immunogenicity per se","volume":"94","author":"Su","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jneuroim.2019.577042_bb0060","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood-2012-11-468264","article-title":"Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells","volume":"122","author":"Trinath","year":"2013","journal-title":"Blood."},{"key":"10.1016\/j.jneuroim.2019.577042_bb0065","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10753-012-9551-5","article-title":"Silencing of miR155 promotes the production of inflammatory mediators in Guillain-Barr\u00e9 syndrome in vitro","volume":"36","author":"Wang","year":"2013","journal-title":"Inflammation."},{"key":"10.1016\/j.jneuroim.2019.577042_bb0070","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/sji.12201","article-title":"Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis","volume":"80","author":"Wang","year":"2014","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jneuroim.2019.577042_bb0075","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.expneurol.2017.02.010","article-title":"IgG-degrading enzyme of streptococcus pyogenes (IdeS) prevents disease progression and facilitates improvement in a rabbit model of Guillain-Barr\u00e9 syndrome","volume":"291","author":"Wang","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2019.577042_bb0080","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cytogfr.2013.05.005","article-title":"Th1\/Th2\/Th17\/Treg cytokines in Guillain-Barr\u00e9 syndrome and experimental autoimmune neuritis","volume":"24","author":"Zhang","year":"2013","journal-title":"Cytokine Growth Factor Rev."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281930308X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281930308X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:34:14Z","timestamp":1759048454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557281930308X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":16,"alternative-id":["S016557281930308X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577042","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous immunoglobulin promotes the proliferation of CD4+CD25+ Foxp3+ regulatory T cells and the cytokines secretion in patients with Guillain-Barr\u00e9 syndrome in vitro","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577042"}}